Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Clinical Roundup

ASCO launches health equity learning collaborative

August 02, 2024
Vol.50 No.31
Clinical Roundup

Research identifies U.S. areas for targeted colorectal cancer screening in Hispanic/Latino communities

August 02, 2024
Vol.50 No.31
In Brief

Newman, Salami named associate directors at UMich Rogel Cancer Center

July 26, 2024
Vol.50 No.30
Clinical Roundup

Socioeconomic status affects survival of children with cancer

July 26, 2024
Vol.50 No.30
In Brief

Thyme Care closes $95M Series C to advance optimization of care, navigation

July 19, 2024
Vol.50 No.29
Clinical Roundup

Living in disadvantaged neighborhoods influences stress-related genes, which may contribute to aggressive prostate cancer in African American men

July 19, 2024
Vol.50 No.29
Clinical Roundup

Cell donor’s socioeconomic status shapes cancer treatment outcomes

July 19, 2024
Vol.50 No.29
NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
Conversation with The Cancer Letter

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

July 12, 2024
Vol.50 No.28
By Paul Goldberg
In Brief

UAMS receives $1.3M for high school-focused tech and data science exposure program

July 12, 2024
Vol.50 No.28
Clinical Roundup

FDA guidance provides new details on diversity action plans for clinical studies

June 28, 2024
Vol.50 No.26

Posts navigation

Previous1…789…29Next

Trending Stories

  • Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • Pam Bondi diagnosed with thyroid cancer
  • The story of daraxonrasib is the ultimate hero’s journey
    A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe
  • As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
  • At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account